Local
Dana-Farber and Beth Israel begin cancer-care partnership with patient transfer, hospital groundbreaking
Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center transferred their first oncology patients under a new clinical partnership Monday. The institutions also marked the start of construction on the Lavine Bekenstein Cancer Hospital with a groundbreaking ceremony.
BOSTON — Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center transferred their first oncology patients under a new clinical partnership Monday, Oct. 19, as the institutions held a groundbreaking ceremony for the Lavine Bekenstein Cancer Hospital.
The two milestones mark a new phase in the hospitals’ long-term cancer-care relationship. Dana-Farber’s previous clinical affiliation was with Brigham and Women’s Hospital, part of Mass General Brigham.
The new hospital project and patient transition are part of Dana-Farber and Beth Israel Deaconess’ collaboration. Further details about the hospital’s construction schedule and capacity were not announced in the information provided.